Scientists Establish Essential Markers to Characterize Human Embryonic Stem Cell Lines
Scientists with the International Stem Cell Initiative have identified a set of common gene expression markers that may be used to reliably characterize diverse human embryonic stem cell lines.
Skin Cells ‘Fight Child Cancer’
Genetically modified skin cells could be used to fight a cancer which strikes the very young.
Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial
A molecularly engineered therapy selectively embeds a gene in pancreatic cancer that shrinks or eradicates tumors, inhibits metastasis, and prolongs survival with virtually no toxicity.
First Lung Transplants in Mice Lay Groundwork for New Drugs to Prevent Transplant Rejection in Humans
Surgeons at Washington University School of Medicine in St. Louis have developed the first mouse model of lung transplantation, and they’re hoping it will help explain why the success of the procedure in humans lags far behind other solid organ transplants.
Beike Biotechnology Study Suggests Adult Stem Cells Show Promise For Peripheral Vascular Disease
Beike Biotechnology Co., Ltd. has announced that a team led by Dr. Yang Xiaofeng at its collaborating hospital in Shenyang completed a study to assess clinical efficacy, safety, and feasibility of transplantation of peripheral blood stem cells for patients with peripheral vascular disease of the lower extremities.
Mesoblast Moves Forward with the Next Phase of Clinical Trials Using “Off-the-Shelf” Stem Cells
Mesoblast Limited has announced the commencement of its first United States-based clinical trial using allogeneic, “off-the-shelf” or universal donor, adult stem cells for patients with intervertebral disc disease and requiring spinal fusion.
Stem Cell Clinical Trials to Begin at Wahlen VA Medical Center
Red tape has held up the work since 2004, but now stem cell researchers at the University of Utah say they are ready to begin clinical trials for a new stem cell therapy at the veterans’ hospital in Salt Lake City.
Injecting Autologous Cells Could Relieve Urinary Incontinence
Transurethral injections of autologous myoblasts and fibroblasts could relieve stress urinary incontinence in women, conclude authors of an article published in The Lancet.
Aldagen Adds Three Clinical Sites to its Critical Limb Ischemia Study
The three additional sites are Duke University Medical Center (Durham, NC), Indiana University (Indianapolis, IN) and Saint Joseph’s Research Institute (Atlanta, GA).
Cell Genesys Completes Patient Recruitment for First Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Cell Genesys, Inc. has announced that it has completed recruitment of over 600 patients into VITAL-1, the first of two ongoing Phase 3 clinical trials of GVAX immunotherapy for prostate cancer.
ViaCell Receives IDE Supplement Approval to Advance ViaCyte Pivotal Trial
ViaCell, Inc. has announced that it has received FDA approval of its investigational device exemption supplement for its ViaCyteSM pivotal clinical trial.
South Korean Lab Looks at Cloning Drug-sniffing Dogs
A South Korean laboratory that produced the world’s first cloned dogs is looking to get into the business of cloning canines, first by cloning drug-sniffing dogs.
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Stem Cell Therapy for Autism
In this article, researchers propose that the combined use of MSC and cord blood CD34+cells may be useful in the treatment of autism.